Stay updated on Nivolumab for Uterine Cancer - Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Uterine Cancer - Clinical Trial page.

Latest updates to the Nivolumab for Uterine Cancer - Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedAdded Revision: v3.4.2. Removed earlier notices including Revision: v3.4.1 and the government funding status notice with links to operating status.SummaryDifference0.4%

- Check17 days agoChange DetectedNotice about government funding lapse and NIH Clinical Center operating status added; revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check24 days agoChange DetectedAdded a glossary toggle and updated QC/versioning labels: 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while removing the older forms 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check38 days agoChange DetectedRevision tag updated to v3.3.4, replacing v3.3.3. This is a minor site maintenance change and does not alter the study details, eligibility criteria, or user actions on the page.SummaryDifference0.1%

- Check60 days agoChange DetectedAdded a new Locations section listing trial sites by state (New Jersey, New York, Pennsylvania). Removed the HHS Vulnerability Disclosure link from the footer.SummaryDifference0.4%

- Check89 days agoChange DetectedPublications section now states entries are automatically filled from PubMed and may not all be about the study. The page revision is updated to v3.3.2, and the previous PubMed description and v3.2.0 revision have been removed.SummaryDifference0.1%

Stay in the know with updates to Nivolumab for Uterine Cancer - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Uterine Cancer - Clinical Trial page.